Street View: Wingstop's disappointing Q3 and continuing pressures
Restaurant chain Wingstop
At least 13 analysts cut PT on WING; average rating of 29 analysts is "buy"; median PT is $325 - data compiled by LSEG
MACRO PRESSURES, SAME POTENTIAL
Stifel ("buy" PT: $300): Co's view that easier comparisons would result in better performance did not play out as consumer backdrop softened more than anticipated
Gordon Haskett ("buy" PT:$285): Sees Q3,Q4 as "low-water mark" for sales, looking for a return to atleast low single digit percentage in 2026
UBS ("neutral" PT: $295): Pressures from challenging macro, increasingly competitive promotional environment are likely to weigh on sales trends through Q4 and into 2026
Bernstein ("outperform" PT: $350): Views broadening consumer pressure in Q3 as temporary, but sees no clear catalysts to lift sentiment heading into FY26
Jefferies ("buy" PT: $350): Says acceleration in 2026 is still attainable, with robust development, visibility under a franchised model limiting downside risk in an uncertain environment
Related Articles
Tesla’s 2025 Shareholder Meeting Showdown: Musk’s Leadership and Tesla’s Crossroads
TradingKey - Tesla (TSLA), the electric vehicle leader, will hold its 2025 Annual Shareholder Meeting on November 6. Dubbed by CEO Elon Musk as a moment that will “decide Tesla’s future and shape the world’s,” the event centers on one pivotal question: Will shareholders approve Musk’s proposed $1 T
What Drove the 'Black Tuesday' Sell-Off? Three Key Factors Behind the U.S. Stock Plunge
TradingKey - On November 4, 2025, U.S. markets suffered a sudden and sharp selloff — dubbed “Black Tuesday” — with the Nasdaq posting its largest single-day drop in a month. The rout unfolded amid growing economic and political instability, as a record-long government shutdown worsened systemic
IonQ Stock Price Skyrockets 300% in a Year, But Recently Drops 30%—Is IonQ Still a Buy?
Is IonQ worth buying? With a recent decline of nearly 30% over the past month, is now the time to buy? How much further could IonQ's stock rise?
Novo Nordisk Q3 Earnings Preview: New CEO, Board Overhaul — Can the U.S. Weight-Loss Market Turn Around?
TradingKey - Novo Nordisk (NVO), one of Europe’s pharmaceutical giants and a leader in the weight-loss drug race, will report its Q3 2025 earnings before market open on November 5. Wall Street expects a modest rebound from Q2’s worst growth in four years, but significant pressure on profits remains.
Palantir Q3 2025 Earnings: Blowout Performance Can’t Hide an AI Bubble， Four Growing Risks Behind a Nearly 1,000x Valuation
TradingKey – After the close of trading on November 4, “AI application King” Palantir Technologies (PLTR) reported its third-quarter earnings for fiscal year 2025. Despite a blowout quarter, surging top-line growth, and a flood of commercial orders, the stock plunged in after-hours trading.
